Giulia Tombesi
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
LRRK2 regulates synaptic function through modulation of actin cytoskeletal dynamics.
Journal: eLife
Published: August 06, 2026
Leucine-rich repeat kinase 2 impairs the release sites of Parkinson's disease vulnerable dopamine axons.
Journal: Nature communications
Published: February 20, 2026
Leucine-rich repeat kinase 2 impairs the release sites of Parkinson's disease vulnerable dopamine axons.
Journal: bioRxiv : the preprint server for biology
Published: September 05, 2025
LRRK2 and the fragile synapse: a molecular prelude to Parkinson's disease?
Journal: The Biochemical journal
Published: July 28, 2025
LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons.
Journal: Molecular psychiatry
Published: September 05, 2024
LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons.
Journal: bioRxiv : the preprint server for biology
Published: June 19, 2024
PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formation.
Journal: Frontiers in molecular neuroscience
Published: July 29, 2023
Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain.
Journal: Cell death & disease
Published: July 25, 2023
Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: November 29, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026